Clinical Trials Browser

Intestinal Neoplasms × camrelizumab × Clear all

NCT05193292 2022-01-14

Camrelizumab Combined With Trastuzumab and Chemotherapy in Patients With HER2-positive Advanced Colorectal Cancer

Phase 2 Unknown

Gastrointestinal

Intestinal Neoplasms, Colorectal Neoplasms